Loading...
Symbols:
Loading...
Symbols:
Mylan Laboratories Inc. (MYL)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Mylan Laboratories Inc. (MYL)
46 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on MYL
- Aaron F. Barkoff(14)
- Bespoke Investment Group(8)
- SA Editor Eli Hoffmann(5)
- Mike Havrilla(3)
- Andrew Wilkinson(2)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(572)
- David Merkel(401)
- SA Editor Eli Hoffmann(386)
- Andrew Wilkinson(333)
- Richard Shaw(238)
Most commented on authors
- Bespoke Investment Group(60)
- SA Editor Eli Hoffmann(17)
- Trader Thoughts(3)
- Asif Suria(3)
- Richard Shaw(3)
- Mylan on the Comeback Trail
- Investing in India's Generic Drug Market
- Wall Street Breakfast: Must-Know News
- Earnings Preview: Mylan
- Six Healthcare Stocks at Sale Prices
- Lowest Estimated PEG Ratios in the Russell 1000
- Generic Drug Industry Outperforms Drug and Healthcare ETFs
- Generic Drugs: In This Market, Portfolios Need Safe, Boring Medicine
- Wednesday Options Update: BSX, GE, MYL, MAS, C, BAC, JPM, XLF, SNDK
- Russell 1000 Stocks with the Highest Short Interest as Percentage of Float
- Being Short New York - Fast Money Recap (9/22/08)
- Wednesday Options Update: CHK, MER, RIGL, MYL, HRS, IR, LIZ
- 31 S&P 500 Stocks with Negative 3 FY Net Income
- NYSE Short Interest Hits Record Highs... Again
- Barr and Mylan Invalidate Boehringer Ingelheim's Patent on Mirapex
- Mylan Prevails Over AstraZeneca in Appeal of Prilosec Case
- NYSE Short Interest Back Near Record Highs
- Wall Street Breakfast: Must-Know News
- Are Healthcare Stocks More Vulnerable to Recession?
- Court Affirms Decision Protecting Ortho-McNeil's Topamax Against Mylan's Generic
- Wall Street Breakfast: Must-Know News
- 20 Winners During a Painful Week
- Healthcare Stocks Have Been Anything but Defensive
- Short Interest by Sector: Consumer Discretionary Leads
- Market Comes Full Circle: Winners and Losers
- China and the Virtualization of Biopharma
- Mylan Labs Ups Stake in China Subsidiary
- Ten Must-Know Stories for Monday
- Portfolio Triage, Part 2
- Court Upholds Validity of AstraZenec's Prilosec Patents
- Mylan Posts $71M Loss, Missing Estimates -- Shares Drop
- Pfizer's Petition for Rehearing in Norvasc Case Denied
- Biotech Buyout Frenzy Continues
- Earnings Preview: Expecting Negative Surprises From Pacific Sunwear, Limited Brands
- Mylan Labs Acquiring Merck KGaA's Generics Unit for $6.7 Billion
- FDA Decision on Pfizer's Norvasc Exclusivity Upheld
- Generics Challenge FDA's Decision On Pfizer Drug
- Mylan Labs Gets FDA Approval for Generic Version of Ambien
- FDA Refuses Approval To Generics Of Pfizer Drug, Except Mylan
- Pfizer and Mylan Fight to Defend Norvasc Against Generics
- Mylan Can Breathe Easy on Norvasc Until April 13
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »